
CAS 197142-34-0
:ácido (1R,3S,5R)-2-[(2-metilpropan-2-il)oxicarbonil]-2-azabiciclo[3.1.0]hexano-3-carboxílico
- (1R,3S,5R)-2-tert-butoxycarbonyl-2-azabicyclo[3.1.0]hexane-3-carboxylic acid
- (1R,3S,5R)-2-aza-bicyclo[3.1.0]hexane-2,3-dicarboxylic acid 2-tert-butyl ester
- (4R,5R)-metano-N-Boc-L-proline
- N-Boc-L-trans-4,5-methanoproline
2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 2-(1,1-dimethylethyl) ester, (1R,3S,5R)-
CAS:Fórmula:C11H17NO4Pureza:97%Forma y color:SolidPeso molecular:227.2570(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid
CAS:(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acidPureza:97%Peso molecular:227.26g/mol(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid
CAS:Fórmula:C11H17NO4Pureza:95%Forma y color:SolidPeso molecular:227.26(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic Acid
CAS:Producto controladoApplications 1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic Acid acts as a reagent in the preparation of fused bicycles end-capped with peptide derivatives as HCV inhibitors. Synthesis of (tert-butoxycarbonyl)azabicyclohexanecarboxylic acid via stereoselective cyclopropanation of pyrroline
References Wang, G., et al.: Tetrahedron Lett., 54, 6722 (2013); Belema, M., et al.: From U.S. Pat. Appl. Publ. (2012), US 20120195857 A1 20120802Fórmula:C11H17NO4Forma y color:NeatPeso molecular:227.26(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic Acid
CAS:(1R,3S,5R)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic Acid is a stereoselective and scalable synthesis of (1R,3S,5R)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid that can be synthesized in a two step sequence with high yield and high stereoselectivity. The cyclopropanation of the carboxylate group with allyl bromide provides the desired product in good yield and high selectivity (>90% ee).
Fórmula:C11H17NO4Pureza:Min. 95%Peso molecular:227.26 g/mol






